Cancer metabolic reprogramming and precision medicine-current perspective DOI Creative Commons
Tingting Gao,

Liuxin Yang,

Yali Zhang

и другие.

Frontiers in Pharmacology, Год журнала: 2024, Номер 15

Опубликована: Окт. 17, 2024

Despite the advanced technologies and global attention on cancer treatment strategies, continues to claim lives adversely affects socio-economic development. Although combination therapies were anticipated eradicate this disease, resilient restorative nature of cancers allows them proliferate at expense host immune cells energetically. This proliferation is driven by metabolic profiles specific type patient. An emerging field exploring reprogramming (MR) predict effective treatments. mini-review discusses recent advancements in MR that have contributed predictive, preventive, precision medicine. Current perspectives mechanisms various types prospects for personalized medicine are essential optimizing outputs necessary

Язык: Английский

IDO1 Promotes the Progression of NSCLC by Regulating the Polarization of M2 Macrophages DOI Creative Commons
Xiaohong Chen, Jie Yao, Mengyu Zhang

и другие.

International Journal of General Medicine, Год журнала: 2023, Номер Volume 16, С. 1713 - 1733

Опубликована: Май 1, 2023

Non-small cell lung cancer (NSCLC) is currently a problem in the clinic and society. Tumor-related macrophages (TAMs) tumor microenvironment (TME) play vital role development of NSCLC.Bioinformatics was used to analyze Indoleamine 2,3-dioxygenase 1 (IDO1) NSCLC correlation its expression with CD163 expression. The IDO1 measured by immunohistochemistry, their colocalization assessed immunofluorescence. M2 macrophage polarization induced, coculture model cells established.Bioinformatics analysis showed that promoted metastasis differentiation inhibited DNA repair. Moreover, positively correlated We discovered related differentiation. In vitro, we increased invasion, proliferation, cells.In conclusion, determined can regulate TAMs promote progression NSCLC, which provides partial theoretical evidence for use inhibitors treatment NSCLC.

Язык: Английский

Процитировано

7

Study on the Role and Mechanism of SLC3A2 in Tumor-Associated Macrophage Polarization and Bladder Cancer Cells Growth DOI Creative Commons
Pei‐Shan Wu,

Lingna Zhao,

Guangqi Kong

и другие.

Technology in Cancer Research & Treatment, Год журнала: 2024, Номер 23

Опубликована: Янв. 1, 2024

Background: Solute carrier family 3 member 2 (SLC3A2) is highly expressed in various types of cancers, including bladder cancer (BLCA). However, the role and mechanism SLC3A2 onset progression BLCA are still unclear. Methods: The interfering plasmid for was constructed transfected into cells. Cell proliferation, invasion, migration abilities were assessed to evaluate impact silencing on cell growth. M1 M2 macrophage polarization markers detected polarization. levels reactive oxygen species (ROS), lipid peroxidation, Fe 2+ , as well expression ferroptosis-related proteins, measured assess occurrence ferroptosis. Ferroptosis inhibitors used verify mechanism. Results: experimental results showed that lines. cells reduced after with SLC3A2. Interference led increase decreased M0 macrophages co-cultured tumor Additionally, interference increased ROS, downregulated solute 7 member11 (SLC7A11) glutathione peroxidase 4 (GPX4), while upregulated acyl-coA synthetase long chain (ACSL4) transferrin receptor 1 (TFR1) proliferation impeded by ferroptosis inhibitors. Conclusion: inhibited growth tumor-associated promoting

Язык: Английский

Процитировано

2

Gut microbiota influence on lung cancer risk through blood metabolite mediation: from a comprehensive Mendelian randomization analysis and genetic analysis DOI Creative Commons
Yizhao Du, Qin Wang, Zongmei Zheng

и другие.

Frontiers in Nutrition, Год журнала: 2024, Номер 11

Опубликована: Сен. 11, 2024

Gut microbiota (GM) and metabolic alterations play pivotal roles in lung cancer (LC) development host genetic variations are known to contribute LC susceptibility by modulating the GM. However, causal links among GM, metabolite, genes, remain be fully delineated.

Язык: Английский

Процитировано

2

Integrative analysis of anoikis-related genes prognostic signature with immunotherapy and identification of CDKN3 as a key oncogene in lung adenocarcinoma DOI
Haotian Qin,

Qichang Wang,

Juan Xu

и другие.

International Immunopharmacology, Год журнала: 2024, Номер 143, С. 113282 - 113282

Опубликована: Окт. 8, 2024

Язык: Английский

Процитировано

2

Cancer metabolic reprogramming and precision medicine-current perspective DOI Creative Commons
Tingting Gao,

Liuxin Yang,

Yali Zhang

и другие.

Frontiers in Pharmacology, Год журнала: 2024, Номер 15

Опубликована: Окт. 17, 2024

Despite the advanced technologies and global attention on cancer treatment strategies, continues to claim lives adversely affects socio-economic development. Although combination therapies were anticipated eradicate this disease, resilient restorative nature of cancers allows them proliferate at expense host immune cells energetically. This proliferation is driven by metabolic profiles specific type patient. An emerging field exploring reprogramming (MR) predict effective treatments. mini-review discusses recent advancements in MR that have contributed predictive, preventive, precision medicine. Current perspectives mechanisms various types prospects for personalized medicine are essential optimizing outputs necessary

Язык: Английский

Процитировано

2